Abstract

The genome of Lactobacillus acidophilus PNW3 was assessed for probiotic and safety potentials. The genome was completely sequenced, assembled using SPAdes, and thereafter annotated with NCBI prokaryotic genome annotation pipeline (PGAP) and rapid annotation using subsystem technology (RAST). Further downstream assessment was determined using appropriate bioinformatics tools. The production of biogenic amines was confirmed through HPLC analysis and the evolutionary trend of the strain was determined through the Codon Tree pipeline. The strain was predicted as a non-human pathogen. A plethora of encoding genes for lactic acids and bioactive peptides production, adhesion molecules, resistance to the harsh gut environmental conditions, and improvement of the host metabolism, which are putative for important probiotic functionalities, were located at different loci within the genome. A bacteriocin predicted to be helveticin J was identified as one of the secondary metabolites. The maximum zone of inhibition exhibited by the crude bacteriocin against STEC E. coli O177 was 21.7 ± 0.58 mm and 24.3 ± 1.15 mm after partial purification (250 µg/mL). Three coding sequences were identified for insertion sequences and one for the CRISPR-Cas fragment. The protein-encoding sequence for Ornithine decarboxylase was found within the genome. L. acidophilus PNW3 presents important features categorizing it as a viable and safe probiotic candidate, though further safety investigations are necessary. The application of probiotics in livestock-keeping would ensure improved public health and food security.

Highlights

  • Lactic acid bacteria (LAB) are widely used as probiotics across host species [1]

  • The aim of this study was to assess the entire genome of L. acidophilus PNW3 in order to determine the genome-based probiotics features which may be present in the strain

  • The sequenced set of reads and complete genome assembly of the Lactobacillus acidophilus PNW3 has been deposited in SRA and the DDBJ/ENA/GenBank under the accession numbers SRX5395058 and SMLT00000000, respectively

Read more

Summary

Introduction

Lactic acid bacteria (LAB) are widely used as probiotics across host species [1]. Lactobacillus acidophilus is a lactic acid bacterium commonly used in dairy industries as a starter culture in the production of high-quality health functional foods, such as yoghurt, cheese and beverages [2].Complete genome sequences have contributed a great deal in the elucidation of the probiotic potentials of lactic acid bacteria [3]. Lactic acid bacteria (LAB) are widely used as probiotics across host species [1]. Lactobacillus acidophilus is a lactic acid bacterium commonly used in dairy industries as a starter culture in the production of high-quality health functional foods, such as yoghurt, cheese and beverages [2]. Complete genome sequences have contributed a great deal in the elucidation of the probiotic potentials of lactic acid bacteria [3]. Several strains of L. acidophilus have been extensively characterized and their probiotic features have been judiciously documented [4]. Studies have indicated that the bioactive secondary metabolites produced by many probiotic agents affect bacterial community interactions and potentially attenuate the disease symptoms caused by pathogens [5,6].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call